Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06155383
Status:
RECRUITING
Last Update Posted:
2023-12-14
First Post:
2023-11-23
Brief Title:
Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma
Sponsor:
Organization:
RemeGen Co Ltd